Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Homosalinosporamide A
2. Npi 0052
3. Npi-0052
4. Salinosporamide A
1. Salinosporamide A
2. 437742-34-2
3. Npi-0052
4. (-)-salinosporamide A
5. Npi 0052
6. Ml 858
7. Salinosporamide A (npi-0052, Marizomib)
8. 703p9ydp7f
9. Chebi:48045
10. (1r,4r,5s)-4-(2-chloroethyl)-1-((s)-((s)-cyclohex-2-en-1-yl)(hydroxy)methyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione
11. (1r,4r,5s)-4-(2-chloroethyl)-1-[(s)-(1s)-cyclohex-2-en-1-yl(hydroxy)methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione
12. Marizomib [usan:inn]
13. Marizomibum
14. Unii-703p9ydp7f
15. Homosalinosporamide A
16. Marizomib [inn]
17. Marizomib (usan/inn)
18. Marizomib [usan]
19. Marizomib [who-dd]
20. Schembl151667
21. Salinosporamide A [mi]
22. Chembl371405
23. Dtxsid00904019
24. (1s,2r,5r)-2-(2-chloroethyl)-5-[(s)-[(1s)-cyclohex-2-en-1-yl]-hydroxymethyl]-1-methyl-7-oxa-4-azabicyclo[3.2.0]heptane-3,6-dione
25. Ex-a3259
26. Zinc3990364
27. Bdbm50398608
28. Akos027323566
29. Db11762
30. Hy-10985
31. Cs-0002986
32. D09640
33. A872651
34. Q7404722
35. (1r,4r,5s)-4-(2-chloroethyl)-1-((s)-((1s)-cyclohex-2-en-1-yl)hydroxymethyl)-5-methyl- 6-oxa-2-azabicyclo(3.2.0)heptane-3,7-dione
36. (1r,4r,5s)-4-(2-chloroethyl)-1-((s)-((s)-cyclohex-2-enyl)(hydroxy)methyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione
37. (1r,4r,5s)-4-(2-chloroethyl)-1-[(s)-[(1s)-cyclohex-2-en-1-yl]-hydroxymethyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione
38. 6-oxa-2-azabicyclo(3.2.0)heptane-3,7-dione, 4-(2-chloroethyl)-1-((s)-(1s)-2-cyclohexen-1-ylhydroxymethyl)-5-methyl-, (1r,4r,5s)-
39. 6-oxa-2-azabicyclo(3.2.0)heptane-3,7-dione, 4-(2-chloroethyl)-1-((s)-(1s)-2-cyclohexen-1-ylhydroxymethyl)-5-methyl-, (1r,4r,5s)-
Molecular Weight | 313.77 g/mol |
---|---|
Molecular Formula | C15H20ClNO4 |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 4 |
Exact Mass | 313.1080858 g/mol |
Monoisotopic Mass | 313.1080858 g/mol |
Topological Polar Surface Area | 75.6 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 508 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 5 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Treatment of malignant glial tumours
ABOUT THIS PAGE
74
PharmaCompass offers a list of Marizomib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Marizomib manufacturer or Marizomib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Marizomib manufacturer or Marizomib supplier.
PharmaCompass also assists you with knowing the Marizomib API Price utilized in the formulation of products. Marizomib API Price is not always fixed or binding as the Marizomib Price is obtained through a variety of data sources. The Marizomib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NPI 0052 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NPI 0052, including repackagers and relabelers. The FDA regulates NPI 0052 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NPI 0052 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of NPI 0052 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A NPI 0052 supplier is an individual or a company that provides NPI 0052 active pharmaceutical ingredient (API) or NPI 0052 finished formulations upon request. The NPI 0052 suppliers may include NPI 0052 API manufacturers, exporters, distributors and traders.
click here to find a list of NPI 0052 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NPI 0052 DMF (Drug Master File) is a document detailing the whole manufacturing process of NPI 0052 active pharmaceutical ingredient (API) in detail. Different forms of NPI 0052 DMFs exist exist since differing nations have different regulations, such as NPI 0052 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NPI 0052 DMF submitted to regulatory agencies in the US is known as a USDMF. NPI 0052 USDMF includes data on NPI 0052's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NPI 0052 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NPI 0052 suppliers with USDMF on PharmaCompass.
NPI 0052 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NPI 0052 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NPI 0052 GMP manufacturer or NPI 0052 GMP API supplier for your needs.
A NPI 0052 CoA (Certificate of Analysis) is a formal document that attests to NPI 0052's compliance with NPI 0052 specifications and serves as a tool for batch-level quality control.
NPI 0052 CoA mostly includes findings from lab analyses of a specific batch. For each NPI 0052 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NPI 0052 may be tested according to a variety of international standards, such as European Pharmacopoeia (NPI 0052 EP), NPI 0052 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NPI 0052 USP).